/
/
/

Fredun Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)1,450.00
Volume (₹)1,034.00
High (₹)1,474.55
Upper Circuit1,745.85
Low (₹)1,440.00
Lower Circuit1,163.95
Prev Close1,454.90
52W High (₹)1,666.35
Price1,473.55
52W Low (₹)454.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)2491.67 Cr
Div. Yield (%)0.02
PE Ratio56.86
Debt to Equity0.84
Price to Book3.46
Book Value160.92
EPS (TTM)25.59
Face Value10.00
ROE (%)16.09

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
FREDUN-BNSE
LTP
1W Low
1W High
Market cap (₹)
1785+6.75 (0.38%)
1720.80
1796.45
4,25,150Cr
9975+260 (2.68%)
9866.35
10080.20
2,66,265Cr
4646.55+11.4 (0.25%)
4555
4665.10
1,76,301Cr
2310.25-81.75 (-3.42%)
2252.50
2442
1,25,352Cr
1260.2+16.2 (1.30%)
1217.70
1264.20
1,23,591Cr
1371.5+21.3 (1.58%)
1337.30
1390.70
1,14,351Cr
1391+11 (0.80%)
1364.75
1400.60
1,12,474Cr
2493.15+4.4 (0.18%)
2457.35
2523.70
1,02,315Cr
1697.2+19.4 (1.16%)
1656.90
1707.60
97,757Cr
2025+16 (0.80%)
1989.10
2061.55
92,007Cr
1473.55+107.5 (7.87%)
1353.05
1474.55
2,492Cr

Key Highlights of Fredun Pharmaceuticals Ltd Balance Sheet

Fredun Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹5.47Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹5.47Cr, and the reserves and surplus of the company is ₹259.33Cr.

The company has its non-current liabilities with total liabilities of ₹642.14Cr as of 2026-03-31.

The current liabilities are ₹296.31Cr as of 2026-03-31. At the same time, current assets are ₹498.24Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹2.02Cr and tangible assets of ₹118.23Cr, provided in the Fredun Pharmaceuticals Ltd financial statements.